Lassa fever remains one of the most pressing public health threats in West Africa. According to the Africa CDC, the viral haemorrhagic fever (VHF) infects between 100,000 and 300,000 people annually, with thousands of deaths recorded across the region. Nigeria and neighbouring countries bear the brunt of recurring outbreaks, with significant challenges in diagnostics, treatment,…
The 2nd ECOWAS Lassa Fever International Conference (#ELFIC 2025) concluded this Thursday 11 September 2025 in Abidjan, Côte d’Ivoire, after four days of high-level discussions, knowledge sharing, and strategic commitments. The gathering brought together more than 800 policymakers, scientists, health professionals, and development partners from across West Africa and beyond to confront one of the…
They warned that continued reliance on external donors threatens the continent’s epidemic preparedness Ahead of the ECOWAS Lassa Fever International Conference 2025 (ELFIC2025), regional health experts have urged African governments to adopt innovative financing models to boost research and vaccine development for Lassa Fever and other emerging diseases. They made the call at a preparatory…
In West Africa, Lassa fever remains a persistent and recurring health threat, causing hundreds of lives each year and underscoring urgent need for sustained investment in research and vaccine manufacturing capacity. In the first five months of 2025 alone, Nigeria reported over 717 confirmed cases and 138 deaths, highlighting the escalating risk and the critical…
